Study Progress of Early Neurological Deterioration Following Intravenous Thrombolysis with Alteplase

doi:10.3969/j.issn.1673-5765.2017.02.020

Abstract

Abstract:

Although the majority of patients with acute ischaemic stroke tends to improve after intravenous thrombolysis with alteplase, there are still certain portion of patients experiencing early neurological deterioration (END) with aggravated symptoms. The definition of END still haven’t been unified, so that there are differences of reported incidence. The precise causes and risk factors of END with clear underlying pathophysiology remain as the hotspot topic to be discussed. In this paper, all of above mentioned contents were reviewed.

Key words: Acute ischaemic stroke; Alteplase; Intravenous thrombolysis; Early neurological deterioration; Causes; Risk factors

摘要：

尽管多数急性缺血性卒中患者经阿替普酶静脉溶栓治疗后症状有所缓解，仍有相当一部分患者经历早期神经功能恶化（early neurological deterioration，END），症状进一步加重。目前学术界对于END的定义尚未统一，因此导致END的发生率不尽相同。关于END确切病因、危险因素以及相关病理生理机制仍是学术界讨论的热点。END的发生强烈提示患者3个月预后不良。本文就以上内容进行综述。

关键词: 急性缺血性卒中; 阿替普酶; 静脉溶栓; 早期神经功能恶化; 病因; 危险因素

CUI Ying, TONG Xu, WANG Yi-Long, et al.. Study Progress of Early Neurological Deterioration Following Intravenous Thrombolysis with Alteplase[J]. Chinese Journal of Stroke, 2017, 12(02): 192-198.

崔颖，佟旭，王伊龙，郑华光，曹亦宾. 阿替普酶静脉溶栓后发生早期神经功能恶化的研究进展[J]. 中国卒中杂志, 2017, 12(02): 192-198.

References

1 卫生部新闻办公室. 第三次全国死因调查主要情况[J].

中国肿瘤，2008，17：344-345.

2 Yang G，Wang Y，Zeng Y，et al. Rapid health

transition in China，1990-2010：findings from the

Global Burden of Disease Study 2010[J]. Lancet，2013，

381：1987-2015.

3 Tissue plasminogen activator for acute ischemic

st roke. The National Institute of Neurological

Disorders and Stroke rt-PA Stroke Study Group[J]. N

Engl J Med，1995，333：1581-1587.

4 Hacke W，Kaste M，Bluhmki E，et al. Thrombolysis

with alteplase 3 to 4. 5 hours after acute ischemic

stroke[J]. N Engl J Med，2008，359：1317-1329.

5 Davis SM，Donnan GA，Parsons MW，et al. Effects

of alteplase beyond 3 h after stroke in the Echoplanar

Imaging Thrombolytic Evaluation Trial (EPITHET)：a

placebo-controlled randomised trial[J]. Lancet Neurol，

2008，7：299-309.

6 Wa h lg r en N，Ahmed N，Dáva l o s A，e t a l .

Thrombolysis with alteplase 3-4. 5 h after acute

ischaemic stroke (SITS-ISTR)：an observational

study[J]. Lancet，2008，372：1303-1309.

7 Saver JL，Altman H. Relationship between neurologic

deficit severity and final functional outcome shifts

and strengthens during first hours after onset[J].

Stroke，2012，43：1537-1541.

8 Dávalos A，Toni D，Iweins F，et al. Neurological

deterioration in acute ischemic stroke：potential

predictors and associated factors in the European

cooperative acute stroke study (ECASS) Ⅰ[J]. Stroke，

1999，30：2631-2636.

9 Kim JM，Moon J，Ahn SW，et al. The etiologies of

early neurological deterioration after thrombolysis

and risk factors of ischemia progression[J]. J Stroke

Cerebrovasc Dis，2016，25：383-388.

10 Zinkstok SM，Beenen LF，Majoie CB，et al. Early

deterioration after thrombolysis plus aspirin in acute

stroke：a post hoc analysis of the Antiplatelet Therapy

in Combination with Recombinant t-PA Thrombolysis

in Ischemic Stroke trial[J]. Stroke，2014，45：3080-

3082.

11 Hacke W，Kaste M，Fieschi C，et al. Randomised

double-blind placebo-controlled trial of thrombolytic

therapy with intravenous alteplase in acute ischaemic

stroke (ECASS Ⅱ). Second European-Australasian

Acute Stroke Study Investigators[J]. Lancet，1998，

352：1245-1251.

12 Wa h lg r en N，Ahmed N，Dáva l o s A，e t a l .

Thrombolysis with alteplase for acute ischaemic stroke

in the Safe Implementation of Thrombolysis in Stroke-

Monitoring Study (SITS-MOST)：an observational

study[J]. Lancet，2007，369：275-282.

13 Mor i M，Naganuma M，Okada Y，et al. Early

neurological deterioration within 24 hours after

intravenous rt-PA therapy for stroke patients：the

Stroke Acute Management with Urgent Risk Factor

Assessment and Improvement rt-PA Registry[J].

Cerebrovasc Dis，2012，34：140-146.

14 Awadh M，MacDougall N，Santosh C，et al. Early

recurrent ischemic stroke complicating intravenous

thrombolysis for stroke：incidence and association

with atrial fibrillation[J]. Stroke，2010，41：1990-1995.

15 Nanri Y，Yakushiji Y，Hara M，et al. Stroke scale

items associated with neurologic deterioration within

24 hours after recombinant tissue plasminogen

activator therapy[J]. J Stroke Cerebrovasc Dis，2013，

22：1117-1124.

16 Simonsen CZ，Schmitz ML，Madsen MH，et al. Early

neurological deterioration after thrombolysis：Clinical

and imaging predictors[J]. Int J Stroke，2016，11：776-

782.

17 Siegler JE，Martin-Schild S. Early neurological

deterioration (END) after stroke：the END depends

on the definition[J]. Int J Stroke，2011，6：211-212.

18 Seners P，Turc G，Oppenheim C，et al. Incidence，

causes and predictors of neurological deterioration

occurring within 24 h following acute ischaemic

stroke：a systematic review with pathophysiological

implications[J]. J Neurol Neurosurg Psychiatry，2015，

86：87-94.

19 Wardlaw JM，Murray V，Berge E，et al. Recombinant

tissue plasminogen activator for acute ischaemic

stroke：an updated systematic review and metaanalysis[

J]. Lancet，2012，379：2364-2372.

20 Strbian D，Sairanen T，Meretoja A，et al. Patient

outcomes from symptomatic intracerebral hemorrhage

after stroke thrombolysis[J]. Neurology，2011，77：

341-348.

21 Tong X，George MG，Yang Q，et al. Predictors

of in-hospital death and symptomatic intracranial

hemorrhage in patients with acute ischemic stroke

treated with thrombolytic therapy：Paul Coverdell

Acute Stroke Registry 2008-2012[J]. Int J Stroke，2014，

9：728-734.

22 Desilles JP，Meseguer E，Labreuche J，et al. Diabetes

mellitus，admission glucose，and outcomes after

stroke thrombolysis：a registry and systematic

review[J]. Stroke，2013，44：1915-1923.

23 Bentley P，Ganesalingam J，Carlton Jones AL，et al.

Prediction of stroke thrombolysis outcome using CT

brain machine learning[J]. Neuroimage Clin，2014，4：

中国卒中杂志 2017年２月第12卷第２期 197

635-640.

24 Dubey N，Bakshi R，Wasay M，et al. Early computed

tomography hypodensity predicts hemorrhage after

intravenous tissue plasminogen activator in acute

ischemic stroke[J]. J Neuroimaging，2001，11：184-

188.

25 Whiteley WN，Emberson J，Lees KR，et al. Risk

of intracerebral haemorrhage with alteplase after

acute ischaemic stroke：a secondary analysis of

an individual patient data meta-analysis[J]. Lancet

Neurol，2016，15：925-933.

26 Treadwell SD，Thanvi B. Malignant middle cerebral

artery (MCA) infarction：pathophysiology，diagnosis

and management[J]. Postgrad Med J，2010，86：235-

242.

27 Battey TW，Karki M，Singhal AB，et al. Brain edema

predicts outcome after nonlacunar ischemic stroke[J].

Stroke，2014，45：3643-3648.

28 Kobayashi M，Tanaka R，Yamashiro K，et al. Preexisting

mobile cardiac thrombus and the risk of early

recurrent embolism after intravenous thrombolysis：a

case report[J]. J Stroke Cerebrovasc Dis，2015，24：

e161-e163.

29 Kamal H，Mowla A，Farooq S，et al. Recurrent

ischemic stroke can happen in stroke patients very

early after intravenous thrombolysis[J]. J Neurol Sci，

2015，358：496-497.

30 Kahles T，Mono ML，Heldner MR，et al. Repeated

intravenous thrombolysis for early recurrent stroke：

challenging the exclusion criterion[J]. Stroke，2016，

47：2133-2135.

31 Jung S，Schindler K，Findling O，et al. Adverse

effect of early epileptic seizures in patients receiving

endovascular therapy for acute stroke[J]. Stroke，2012，

43：1584-1590.

32 Alvarez V，Rossetti AO，Papavasileiou V，et al. Acute

seizures in acute ischemic stroke：does thrombolysis

have a role to play?[J]. J Neurol，2013，260：55-61.

33 Seners P，Turc G，Tisserand M，et al. Unexplained

early neurological deterioration after intravenous

thrombolysis：incidence，predictors，and associated

factors[J]. Stroke，2014，45：2004-2009.

34 Tisserand M，Seners P，Turc G，et al. Mechanisms

of unexplained neurological deterioration after

intravenous thrombolysis[J]. Stroke，2014，45：3527-

3534.

35 Reuter B，Gumbinger C，Sauer T，et al. Intravenous

thrombolysis for acute ischaemic stroke in the

elderly：data from the Baden-Wuerttemberg Stroke

Registry[J]. Eur J Neurol，2016，23：13-20.

36 Mione G，Ducrocq X，Thilly N，et al. Outcome

of intravenous recombinant tissue plasminogen

activator for acute ischemic stroke in patients aged

over 80 years[J]. Geriatr Gerontol Int，2016，16：

843-849.

37 Alvarez-Sabín J，Mol ina CA，Montaner J，et

al. Effects of admission hyperglycemia on stroke

outcome in reperfused tissue plasminogen activator--

treated patients[J]. Stroke，2003，34：1235-1241.

38 Ennis SR，Keep RF. Effect of sustained-mild and

transient-severe hyperglycemia on ischemia-induced

blood-brain barrier opening[J]. J Cereb Blood Flow

Metab，2007，27：1573-1582.

39 Hou Q，Zuo Z，Michel P，et al. Influence of chronic

hyperglycemia on cerebral microvascular remodeling：

an in vivo study using per fusion computed

tomography in acute ischemic stroke patients[J].

Stroke，2013，44：3557-3560.

40 Morita N，Harada M，Uno M，et al. Evaluation of

initial diffusion-weighted image findings in acute

stroke patients using a semiquantitative score[J].

Magn Reson Med Sci，2009，8：47-53.

41 Haeusler KG，Gerischer LM，Vatankhah B，et al.

Impact of hospital admission during nonworking

hours on patient outcomes after thrombolysis for

stroke[J]. Stroke，2011，42：2521-2525.

42 Whiteley WN，Slot KB，Fernandes P，et al. Risk

factors for intracranial hemorrhage in acute ischemic

stroke patients treated with recombinant tissue

plasminogen activator：a systematic review and metaanalysis

of 55 studies[J]. Stroke，2012，43：2904-2909.

43 Strbian D，Meretoja A，Putaala J，et al. Cerebral

edema in acute ischemic stroke patients treated with

intravenous thrombolysis[J]. Int J Stroke，2013，8：

529-534.

44 Tiainen M，Meretoja A，Strbian D，et al. Body

temperature，blood infection parameters，and

outcome of thrombolysis-treated ischemic stroke

patients[J]. Int J Stroke，2013，8：632-638.

45 Cermak J，Key NS，Bach RR，et al. C-reactive

protein induces human peripheral blood monocytes to

synthesize tissue factor[J]. Blood，1993，82：513-520.

46 Villemure C，Bushnell MC. Mood inf luences

supraspinal pain processing separately f rom

attention[J]. J Neurosci，2009，29：705-715.

47 Baizabal-Carvallo JF，Alonso-Juarez M，Samson Y.

Clinical deterioration following middle cerebral artery

hemodynamic changes after intravenous thrombolysis

for acute ischemic stroke[J]. J Stroke Cerebrovasc Dis，

2014，23：254-258.

48 We i X E，Zhao YW，Lu J，et a l . Timi ng of

recanalization and outcome in ischemic-stroke

198 Chin J Stroke, Feb 2017, Vol 12, No.2

patients treated with recombinant tissue plasminogen

activator[J]. Acta Radiol，2015，56：1119-1126.

49 Kim YD，Lee JH，Jung YH，et al. Effect of warfarin

withdrawal on thrombolytic treatment in patients with

ischaemic stroke[J]. Eur J Neurol，2011，18：1165-

1170.

50 Lou M，Selim M. Does body weight influence the

response to intravenous tissue plasminogen activator

in stroke patients?[J]. Cerebrovasc Dis，2009，27：84-

90.

51 Kim JT，Park MS，Chang J，et al. Proximal arterial

occlusion in acute ischemic stroke with low NIHSS

scores should not be considered as mild stroke[J].

PLoS One，2013，8：e70996.

[1]	WANG Xiaorui, LUO Song, ZOU Liangyu, QU Hongdang, CUI Xue, ZHAO Yujie. Value of Eosinophil-to-Monocyte Ratio in Predicting the Prognosis of Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis [J]. Chinese Journal of Stroke, 2024, 19(9): 1025-1033.
[2]	DING Zeyu, JI Zeqiang, WU Jianwei, KANG Kaijiang, ZHAO Xingquan. Risk Factors of Early Neurological Deterioration of Patients after Minimally Invasive Surgery in Supratentorial Hypertensive Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(5): 545-551.
[3]	DING Zeyu, LI Guangshuo, ZHAO Xingquan. Relationship between High Levels of Fasting Blood Glucose and Functional Outcome after Intravenous Thrombolysis in Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(3): 293-298.
[4]	ZHENG Jianhua, CUI Yanling, CAO Ying, DAI Jianwu. A Case Report of Capsule Warning Syndrome Treated with Tirofiban Bridging Dual Antiplatelet Therapy after Intravenous Thrombolysis with Alteplase [J]. Chinese Journal of Stroke, 2024, 19(3): 326-330.
[5]	BU Hongjing, MA Na, ZHANG Panpan, LIU Yuanhong. Establishment and Verification of Nomogram of Early Neurological Deterioration in Patients with Acute Penetrating Artery Infarction [J]. Chinese Journal of Stroke, 2024, 19(2): 158-166.
[6]	WANG Yongjun, XIONG Yunyun, LI Guangshuo, CAO Zhixin, WANG Wenjie, YAN Ran, WANG Liyuan, LU Zhengzhao, HAO Manjun. Highlights in Stroke in 2023 [J]. Chinese Journal of Stroke, 2024, 19(1): 1-21.
[7]	YANG Jiaxin, HE Chunyu, LIU Lei, CHEN Wenbo, XIE Yan. Prediction Models of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: A Systematic Review [J]. Chinese Journal of Stroke, 2024, 19(1): 76-86.
[8]	. Effects of Post-stroke Infection on Discharge Outcomes in Patients with Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2023, 18(8): 885-890.
[9]	LI Zhenhua, ZHANG Jiangang, XIE Weizheng, WANG Yu, LUO Xue, LIU Conghui, SUN Ke, YANG Qingcheng, GUO Yanping. Efficacy and Safety Study of Dual Antiplatelet Versus Alteplase in the Treatment of Acute Mild Non-Disabling Ischemic Stroke [J]. Chinese Journal of Stroke, 2023, 18(12): 1391-1396.
[10]	Chinese Stroke Association. CSA Declaration of Next-generation Reperfusion Therapy for Ischemic Stroke [J]. Chinese Journal of Stroke, 2023, 18(12): 1465-1466.
[11]	WANG Lu, WANG Jian. Advances in the Study of Early Neurological Deterioration in Patients with Branch Atheromatous Disease [J]. Chinese Journal of Stroke, 2023, 18(10): 1191-1195.
[12]	ZONG Lixia, GU Hongqiu, YANG Xin, JIANG Yingyu, LI Zixiao, WANG Chunjuan. Trend of Intravenous Thrombolysis and a Comparative Analysis of In-hospital Outcomes of Intravenous Thrombolysis with Alteplase or Urokinase in Acute Ischemic Stroke in China from 2016 to 2022 [J]. Chinese Journal of Stroke, 2023, 18(10): 1202-1208.
[13]	WANG Bei, TAN Bo, ZHANG Yue, LIU Yongdong, YANG Jiaqiang, ZOU Xueli, JIAO Yang, SUN Haijing. Risk Factors of Secondary Cerebral Infarction after Trepanation and Drainage in Patients with Hypertensive Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2023, 18(05): 564-571.
[14]	ZHENG Xin, GUO Junping, ZHANG Runhua, JI Ruijun. Risk Factors of Lower Extremity Deep Vein Thrombosis in Patients with Acute Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2023, 18(05): 577-582.
[15]	LIU Tiantian, HUO Huiyong, XIANG Shifeng, LIU Chao, ZHANG Wenchao, LI Juntao. Relationship between Early Neurological Deterioration and Lenticulostriate Arteries Morphology in Patients with Single Subcortical Infarction [J]. Chinese Journal of Stroke, 2023, 18(02): 208-212.